Yamamoto, Fumiko
Unno, Yuriko
Okamura, Tomoo
Ikeda, Rie
Ochiai, Kaori
Hayashi, Naoyuki
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
https://doi.org/10.1007/s13300-019-00723-x
Funding for this research was provided by:
Nippon Boehringer Ingelheim Co Ltd
Eli Lilly Japan KK
Article History
Received: 28 August 2019
First Online: 11 November 2019